Ranking of Decreasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
Solasia Pharma 4597 TSE Growth	33	-1 -2.9%	22,753,000	10.87	24,394,500	-1,749,300	8.59B	Slightly High
OncoTherapy Science 4564 TSE Growth	22	0 ー%	24,040,600	1.71	17,904,100	-873,700	7.45B	Mid
RECOMM 3323 TSE Standard	83	+2 +2.47%	799,000	0.00	6,446,200	-696,100	6.86B	Slightly High
BrightPath Biotherapeutics 4594 TSE Growth	51	0 ー%	337,300	8.86	12,452,400	-690,100	5.68B	Slightly High
GEXEED 3719 TSE Standard	281	-13 -4.4%	639,500	0.00	4,625,800	-533,100	7.83B	Slightly High
REVOLUTION 8894 TSE Standard	55	-2 -3.5%	131,800	142.17	7,378,800	-518,800	6.42B	Slightly High
CellSeed 7776 TSE Growth	265	-3 -1.1%	524,800	0.00	3,145,700	-444,700	9.19B	High
SystemSoft 7527 TSE Standard	65	0 ー%	837,900	0.00	9,543,400	-379,900	5.51B	Slightly High
JELLY BEANS 3070 TSE Growth	85	0 ー%	143,900	0.00	10,946,800	-375,400	6.67B	Slightly High
GlobalX Gold 425A TSE ETF	348.8	+0.2 +0.06%	124,420	0.00	1,992,130	-349,350	9.03B	High
Modalis Therapeutics 4883 TSE Growth	63	-1 -1.6%	264,600	0.00	11,050,000	-344,700	5.15B	Slightly High
TAY TWO 7610 TSE Standard	137	0 ー%	311,200	33.81	5,680,700	-333,100	9.41B	Mid
Chiome Bioscience 4583 TSE Growth	113	+1 +0.89%	322,300	0.00	5,061,700	-325,700	7.69B	High
WHY HOW DO COMPANY 3823 TSE Standard	58	+4 +7.41%	4,442,300	51,536.00	10,307,200	-258,300	7.62B	High
Hiramatsu 2764 TSE Standard	115	+1 +0.88%	17,600	0.00	1,503,700	-247,200	8.6B	Mid
Medrx 4586 TSE Growth	115	-2 -1.7%	318,100	0.00	6,953,500	-188,300	6.83B	Slightly High
FUKUSHIMA BANK 8562 TSE Standard	256	-4 -1.5%	174,200	3.33	837,800	-183,400	8.93B	Mid
TECHNOLOGIES Inc 5248 TSE Growth	551	+4 +0.73%	27,000	0.00	3,482,900	-174,200	9.32B	Mid
Tsubota Lab 4890 TSE Growth	343	0 ー%	13,400	0.00	566,700	-151,000	8.85B	Mid
Forside 2330 TSE Standard	175	-3 -1.7%	207,000	0.00	5,193,100	-127,200	7.65B	Slightly High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels